NOVEL TRANSDERMAL ANTI-ANGINAL PHARMACEUTICAL DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION

摘要

Novel transdermal nitroglycerin or other anti-anginal pharmaceutical polymer matrix dosage units have been developed which comprise a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed, and a biologically acceptable adhesive polymer layer which has dispersed one or more skin permeation enhancers. Novel process of administration of the anti-anginal pharmaceutical using the novel polymer matrix dosage units is also provided.